Taking on endogenous Cushing syndrome with Korlym®

Korlym (mifepristone) is a prescription medicine used to treat high blood sugar (hyperglycemia) caused by high cortisol levels in the blood (hypercortisolism) in adults with endogenous Cushing syndrome who have type 2 diabetes mellitus or glucose intolerance and who cannot have surgery or for whom surgery has failed. Korlym is not for people who have type 2 diabetes mellitus not caused by Cushing syndrome.

Learn more about KorlymLearn more about Cushing syndrome

Why Korlym?

Korlym is a once-daily oral treatment that helps reduce certain negative effects of excess cortisol activity. Learn more to see if Korlym is right for you.

What to expect from Korlym

Starting treatment with Korlym

Watch this short video to learn important information about Korlym and what to expect during treatment.

Watch video

Personalized support throughout treatment

A dedicated team of experts is available to provide support while taking Korlym.

Learn more

Find inspiration in real patient stories

Angela standing with her husband, son, and their dog in front of their home.

Angela’s journey

Angela’s path to diagnosis wasn’t easy, but she never stopped pushing for answers. Discover her determination to find a diagnosis and learn what changed for her after starting Korlym.

A profile view of Mark, an older man with a white beard and glasses, wearing a baseball cap and looking thoughtfully to the outdoors.

Mark’s story

For years, Mark searched for answers to his health issues. He refused to give up, even when hope felt out of reach. Hear Mark share his journey on finding a diagnosis and starting a new chapter with Korlym.